Biologics X 3DCC 2026 is a landmark biopharma summit merging the annual Summit on Biopharmaceutical Product Development with the International Conference on Advances in 3D Cell Culture. The two-day event unites global leaders, researchers, and innovators in biologics, biosimilars, cell-based models, and translational science to foster collaboration, cutting-edge research, and future therapy development.

Biologics 2026: Emerging Frontiers Summit is a premier biopharmaceutical conference in Goa focused on biologics product development, bioprocess innovation, regulatory strategy, advanced analytics, and digital biomanufacturing. It unites industry leaders, researchers, startups, and innovators to discuss cutting-edge technologies, collaborative opportunities, and the future of biologics, biosimilars, and therapeutic platforms.

At the 3rd World Congress on Biologics and Biosimilars, leading scientists, biopharma executives, regulators, and clinicians will gather to discuss breakthroughs in biologics R&D, biosimilar commercialization, and next‑generation therapies. Key themes include immunogenicity risk, AI in biologics, oncology applications, gene and cell therapy integration, and global market expansion.

The Biosimilars Congregation 2026 in Mumbai unites pharma, biotech, regulators, and payers to advance biosimilar development and access. Covering regulatory updates, clinical trials, manufacturing, and commercialization, the event offers practical insights and networking to drive biosimilar innovation, affordability, and global market success.